QA: ATOSSA THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001488039_2023_ATOSSA_THERAPEUTICS_INC.pdf

Logs

Graph

Absolute values for 0001488039, ATOSSA THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 118,197,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 5,335,000
4 LiabilitiesCurrent 5,568,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,608,000
9 ResearchAndDevelopmentExpense 15,083,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 731,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 123,532,000
1 Liabilities 5,568,000
2 Expenses 27,691,000
3 Revenues 0
4 StockholdersEquity 117,964,000
5 NetIncome -26,960,000
6 ComprehensiveNetIncome -26,960,000
7 BaseVar 78,761,000
8 EconomicCapitalRatio 2.73

Edgar->Model Mapping

Feature Distribution

Change over Time